Proving Economic Viability
For early-stage companies, generally viewed as unproven, Geomega’s Mathieu Bourdeau says it’s critical to factor in contingencies and ‘be quite conservative in our margins, while being able to think outside the box.’
For early-stage companies, generally viewed as unproven, Geomega’s Mathieu Bourdeau says it’s critical to factor in contingencies and ‘be quite conservative in our margins, while being able to think outside the box.’
A look at how a host of brands are becoming fintech disruptors—and the questions CEOs and CFOs should be asking about embedded finance.
Investors seem to be infatuated with SPACs, but, while there are advantages, there are also many potential pitfalls and hurdles for those managing the transaction. An overview.
As business braces for Biden’s ‘Made in America’ tax and regulatory pressures, here’s what you need to know.
CFO Jeffrey F. Biunno of CohBar, a California clinical stage biotechnology company, talks capital raising and what it’s like to run the finance office from clear across the country.
PCSB’s Jeff Helf talks PPP challenges and rewards, and how the program gave the community bank an edge over big bank competitors.